Monopar Therapeutics insider trading

MNPRNASDAQ

$77.970.00 (0.00%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-19.8%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25

Unlock quarterly net flow

Key players

DHDiane Hendricks10% Owner9.8527%of company
CRChandler RobinsonChief Executive Officer2.496%of company
ACAndrew CittadineChief Operating Officer0.8649%of company
CMChristopher M. StarrDirector0.2243%of company
LTLavina TalukdarDirector0.2086%of company
KRKim R. TsuchimotoDirector0.1711%of company
AJArthur J. KlausnerDirector0.1305%of company
RARaymond AndersonDirector0.08%of company
PRPatrice RiouxOfficer0.0755%of company
QAQuan Anh VuChief Financial Officer0.0396%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
MNPR	Quan Anh VuChief Financial Officer	Open market purchase$105K	Not reported	$69.95	$105K	Dec 26, 2025	Dec 29, 2025
MNPR	Arthur J. KlausnerDirector	Open market sell$31.4K	-5.0%	$68.09	$31.4K	Dec 18, 2025	Dec 19, 2025
MNPR	Arthur J. KlausnerDirector	Open market sell$312K	-33.6%	$67.06	$312K	Dec 18, 2025	Dec 19, 2025

End of history · 3 transactions